Khaitan & Co advised Trinity Life Sciences on Indian law aspects of its strategic multi-jurisdictional acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East, and specifically on the India acquisition which by way of slump sale on a going concern basis. In conjunction with the acquisition, Trinity and EVERSANA have also entered into a strategic collaboration to benefit shared life sciences clients in the region.
The Firm was involved in advising Trinity on all India related legal aspects of the transaction including conducting legal due diligence on EVERSANA India; structuring of the India transaction; advising on, drafting, negotiating and finalizing the transaction documents with respect to the India slump sale and India-related aspects of the global transaction; and advising on all Indian regulatory aspects.
The deal was assisted by:
Corporate & Commercial: Prakruti Shah (Associate) and Abheepsita Purkayastha (Associate)
Employment, Labour & Benefits: Deepak Kumar (Partner) and Ananya Gandhi (Associate)
Direct Tax: Ritu Shaktawat (Partner) and Husain Bohra (Senior Associate)
Indirect Tax: Dinesh Agrawal (Executive Director) and Sachi Upadhyaya (Senior Associate)
Dispute Resolution: Kingshuk Banerjee (Partner)
The core deal team consisted of Niren Patel (Partner) and Param Gupta (Senior Associate).